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As a result of an error in absolute numbers and units, the number of plaques in Figure 2B refers to an arbitrary area taken during each
measurement and does not reflect 1 mm2. The corrected version of the figure and figure legend are shown below. The correction
does not affect the conclusions of the paper. The authors apologize for any confusion caused by this error.Figure 2. CP-113,818 Treatment for 57 Days Mark-
edly Reduces Amyloid Load in the Brains of hAPP
Transgenic Mice
(A) Representative amyloid staining (using thioflavin S) and
Ab staining (using the antibody 6E10) of female hAPP
mouse cortices at 6.5 months of age following placebo
and CP-113,818 treatments. Ab staining of cortices at
day 0 (at 4 months of age) without and, at day 57, with
CP-113,818 treatment was remarkably similar, suggesting
that the ACAT inhibitor prevented formation of amyloid
pathology in these mice.
(B, corrected) Quantitative analysis of brain plaque load,
as assessed by number of plaques per mm2 stained with
the Ab-specific antibody 6E10. In the hAPP animal model,
the cortex is the first to develop amyloid pathology, fol-
lowed by the hippocampus. Therefore, at 6.5 months of
age, males exhibit distinct AD pathology in the cortex
but not in the hippocampus. CP-113,818 reduced cortical
plaque number by 89%, similarly in females (89%) and
males (97%). The most marked effect was observed in
the hippocampus of female mice, where amyloid load
was decreased by 98%, p < 0.0000004.
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